Previous Article | Next Article 
Clinical and Diagnostic Laboratory Immunology, May 1999, p. 392-399, Vol. 6, No. 3
1071-412X/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
Molecular Cloning of the Gene for a Conserved Major
Immunoreactive 28-Kilodalton Protein of Ehrlichia canis:
a Potential Serodiagnostic Antigen
Jere W.
McBride,
Xue-jie
Yu, and
David H.
Walker*
Department of Pathology and WHO Collaborating
Center for Tropical Diseases, University of Texas Medical Branch,
Galveston, Texas 77555-0609
Received 24 August 1998/Returned for modification 23 November
1998/Accepted 14 January 1999
 |
ABSTRACT |
A gene encoding a 28-kDa protein of Ehrlichia canis was
cloned, sequenced, and expressed, and a comparative molecular analysis with homologous genes of E. canis, Cowdria
ruminantium, and Ehrlichia chaffeensis was performed.
The complete gene has an 834-bp open reading frame encoding a protein
of 278 amino acids with a predicted molecular mass of 30.5 kDa. An
N-terminal signal sequence was identified, suggesting that the protein
undergoes posttranslational modification to a mature 27.7-kDa protein
(P28). The E. canis p28 gene has significant nucleic acid
and amino acid sequence homologies with the E. chaffeensis
outer membrane protein-1 (omp-1) gene family, with the
Cowdria ruminantium map-1 gene, and with other E. canis 28-kDa-protein genes. Southern blotting revealed the
presence of at least two additional homologous p28 gene
copies in the E. canis genome, confirming that
p28 is a member of a polymorphic multiple-gene family.
Amino acid sequence analysis revealed that E. canis P28 has
four variable regions, and it shares similar surface-exposed regions,
antigenicity, and T-cell motifs with E. chaffeensis P28.
The p28 genes from seven different E. canis isolates were identical, indicating that the gene for this major immunoreactive protein is highly conserved. In addition, reactivity of
sera from clinical cases of canine ehrlichiosis with the recombinant P28 demonstrated that the recombinant protein may be a reliable serodiagnostic antigen.
 |
INTRODUCTION |
Canine ehrlichiosis, also known as
canine tropical pancytopenia, is a tick-borne rickettsial disease of
dogs that was first described in Africa in 1935 and in the United
States in 1963 (9, 10). The disease received more attention
and recognition after an epizootic outbreak occurred in U.S. military
dogs during the Vietnam War (29). The etiologic agent of
canine ehrlichiosis is Ehrlichia canis, a small,
gram-negative, obligate intracellular bacterium that exhibits tropism
for mononuclear phagocytes (18) and is transmitted by the
brown dog tick, Rhipicephalus sanguineus (11).
The progression of canine ehrlichiosis occurs in three phases, acute,
subclinical, and chronic. The acute phase is characterized by fever,
anorexia, depression, lymphadenopathy, and mild thrombocytopenia (27). Dogs typically recover from the acute phase but become persistently infected carriers of the organism without clinical signs
of disease for months or even years (12). A chronic phase characterized by thrombocytopenia, hyperglobulinemia, anorexia, emaciation, and hemorrhage, particularly epistaxis, followed by death
develops in some cases (27).
Molecular taxonomic analysis based on the 16S rRNA gene has determined
that E. canis and Ehrlichia chaffeensis, the
etiologic agent of human monocytotropic ehrlichiosis, are closely
related (2, 3, 6, 8). Considerable cross-reactivity of the 64-, 47-, 40-, 30-, 29-, and 23-kDa antigens of E. canis and
E. chaffeensis has been reported (5, 6, 22, 23).
Analysis of immunoreactive antigens with human and canine
convalescent-phase sera by immunoblotting has resulted in the
identification of immunodominant proteins of E. canis,
including a 29-kDa protein (5). In addition, a 30-kDa
protein of E. canis has been described as a major
immunodominant antigen recognized early in the immune response and is
antigenically distinct from the 30-kDa protein of E. chaffeensis (22, 23). Other immunodominant proteins of
E. canis with molecular masses ranging from 20 to 30 kDa
have also been identified (4-6, 17).
Recently, cloning and sequencing of a multigene family
(omp-1) encoding proteins of 23 to 28 kDa have been
described for E. chaffeensis (19). The gene
(p28) for the 28-kDa immunodominant outer membrane protein
of E. chaffeensis, which is homologous to the Cowdria
ruminantium map-1 gene, was cloned, and mice immunized with
recombinant P28 were protected against challenge infection with the
homologous strain based on PCR analysis of peripheral blood 5 days
after challenge (19). Molecular cloning of two similar, but
nonidentical, tandemly arranged E. canis 28-kDa-protein genes homologous to the E. chaffeensis omp-1 gene family and
the C. ruminantium map-1 gene has also been reported
(21).
In this study, we describe the molecular cloning, sequencing,
characterization, and expression of the gene (designated
p28) for a conserved mature 28-kDa immunoreactive protein of
E. canis and the presence of a p28 polymorphic
multigene family in E. canis. Comparison with E. chaffeensis and other E. canis 28-kDa-protein genes
revealed that this gene has the most amino acid homology with the
E. chaffeensis omp-1 multigene family. E. canis
P28 is a highly conserved major immunodominant protein, and reactivity of sera from clinical canine ehrlichiosis cases with
recombinant P28 suggests that the recombinant P28 may be a reliable
serodiagnostic antigen.
 |
MATERIALS AND METHODS |
Ehrlichiae and purification.
The E. canis Florida
strain and isolates Demon, DJ, Jake, and Fuzzy were kindly provided by
Edward Breitschwerdt, (College of Veterinary Medicine, North Carolina
State University, Raleigh). The E. canis Louisiana strain
was kindly provided by Richard E. Corstvet (School of Veterinary
Medicine, Louisiana State University, Baton Rouge), and the E. canis Oklahoma strain was kindly provided by Jacqueline Dawson
(Centers for Disease Control and Prevention, Atlanta, Ga.). Propagation
of ehrlichiae was performed in DH82 cells with Dulbecco modified Eagle
medium supplemented with 10% bovine calf serum and 2 mM
L-glutamine at 37°C. The intracellular growth in DH82
cells was monitored by the presence of E. canis morulae by
using general cytologic staining methods. Cells were harvested when
100% of the cells were infected with ehrlichiae and were then pelleted
in a centrifuge at 17,000 × g for 20 min. Cell pellets
were disrupted with a Braun-Sonic 2000 sonicator twice at 40 W for
30 s on ice. Ehrlichiae were purified as described previously
(30). The lysate was loaded onto discontinuous gradients of
42, 36, and 30% Renografin and centrifuged at 80,000 × g for 1 h. Heavy and light bands containing
ehrlichiae were collected, washed with
sucrose-phosphate-glutamate buffer (218 mM sucrose, 3.8 mM
KH2PO4, 7.2 mM K2HPO4,
4.9 mM glutamate, pH 7.0), and pelleted by centrifugation.
Nucleic acid preparation.
E. canis genomic DNA was
prepared by resuspending the Renografin-purified ehrlichiae in 600 µl
of 10 mM Tris-HCl buffer (pH 7.5) with 1% (wt/vol) sodium dodecyl
sulfate (SDS) and 100 ng of proteinase K per ml as described previously
(15). This mixture was incubated for 1 h at 56°C, and
the nucleic acids were extracted twice with phenol-chloroform-isoamyl
alcohol (24:24:1). DNA was pelleted by absolute ethanol precipitation,
washed once with 70% ethanol, dried, and resuspended in 10 mM Tris (pH
7.5). Plasmid DNA was purified by using a High Pure Plasmid Isolation
Kit (Boehringer Mannheim, Indianapolis, Ind.), and PCR products were
purified by using a QIAquick PCR Purification Kit (Qiagen, Santa
Clarita, Calif.).
PCR amplification of the E. canis p28 gene.
Regions of the E. canis p28 gene selected for PCR
amplification were chosen based on homology (>90%) observed in the
consensus sequence generated from Jotun-Hein algorithm alignment of the E. chaffeensis p28 and C. ruminantium map-1
genes. Forward primer 793 (5'-GCAGGAGCTGTTGGTTACTC-3') and
reverse primer 1330 (5'-CCTTCCTCCAAGTTCTATGCC-3') corresponded to nucleotides 313 to 332 and 823 to 843, respectively, of C. ruminantium map-1 and to nucleotides 307 to 326 and 814 to 834, respectively, of E. chaffeensis p28. E. canis DNA (from a North Carolina isolate, Jake) was amplified with
primers 793 and 1330 with a thermal cycling profile of 95°C for 2 min
and 30 cycles of 95°C for 30 s, 62°C for 1 min, and 72°C for
2 min, followed by a 72°C extension for 10 min and a 4°C hold. PCR
products were analyzed in 1% agarose gels. This amplified PCR product
was sequenced directly with primers 793 and 1330.
Sequencing of unknown 5' and 3' regions of the p28
gene.
The full-length sequence of E. canis p28 was
determined by using a Universal GenomeWalker Kit (Clontech, Palo Alto,
Calif.) according to the protocol supplied by the manufacturer. Genomic E. canis DNA (Jake isolate) was digested completely with
five restriction enzymes (DraI, EcoRV,
PvuII, ScaI, and StuI) which produce
blunt-ended DNA. An adapter (AP1) supplied in the kit was ligated to
each end of the E. canis DNA. The genomic libraries were
used as templates to find the unknown DNA sequence of the p28 gene by PCR with a primer complementary to a known
portion of the p28 sequence and a primer specific for the
adapter AP1. Primers specific for p28, used for genome
walking, were designed from the known DNA sequence derived from PCR
amplification of E. canis p28 with primers 793 and 1330. Primers 394 (5'-GCATTTCCACAGGATCATAGGTAA-3'; nucleotides 687 to 710) and 394C (5'-TTACCTATGATCCTGTGGAAATGC-3'; nucleotides 710 to 687) were used in conjunction with supplied primer AP1 to amplify the unknown 5' and 3' regions of the
p28 gene by PCR. A PCR product corresponding to the 5'
region of the p28 gene amplified with primers 394C and AP1
(2,000 bp) was unidirectionally sequenced with primer 793C
(5'-GAGTAACCAACAGCTCCTGC-3'). A PCR product corresponding to
the 3' region of the p28 gene amplified with primers 394 and
AP1 (580 bp) was bidirectionally sequenced with the same primers.
Noncoding regions on the 5' and 3' regions adjacent to the open reading
frame were sequenced, and primers EC28OM-F
(5'-TCTACTTTGCACTTCCACTATTGT-3') and EC28OM-R
(5'-ATTCTTTTGCCACTATTTTTCTTT-3') complementary to
these regions were designed in order to amplify the entire
p28 gene.
DNA sequencing.
DNA was sequenced with an ABI Prism 377 DNA
sequencer (Perkin-Elmer Applied Biosystems, Foster City, Calif.).
Sequencing of p28 genes from E. canis
isolates.
The entire p28 gene from seven E. canis isolates (four from North Carolina and one each from
Oklahoma, Florida, and Louisiana) were amplified by PCR with primers
EC28OM-F and EC28OM-R with a thermal cycling profile of 95°C for 5 min; 30 cycles of 95°C for 30 s, 62°C for 1 min, and 72°C
for 2 min; and a 72°C extension for 10 min. The resulting PCR
products were bidirectionally sequenced with the same primers.
Cloning and expression of E. canis p28.
The entire
E. canis p28 gene was PCR amplified with primers EC28OM-F
and EC28OM-R and cloned into the pCR2.1-TOPO TA cloning vector to
obtain the desired set of restriction enzyme cleavage sites
(Invitrogen, Carlsbad, Calif.). The insert was excised from pCR2.1-TOPO
with BstXI and ligated into the pcDNA 3.1 eukaryotic expression vector (Invitrogen) (designated pcDNA3.1/EC28 for subsequent studies). The pcDNA3.1/EC28 plasmid was amplified, and the gene was
excised with a KpnI-XbaI double digestion and
directionally ligated into the pThioHis prokaryotic expression vector
(Invitrogen). The clone (designated pThioHis/EC28) produced a
recombinant thioredoxin fusion protein in Escherichia coli
BL21. The recombinant fusion protein was crudely purified in the
insoluble phase by centrifugation. The control thioredoxin fusion
protein was purified from soluble cell lysates under native conditions
by using nickel-nitrilotriacetic acid spin columns (Qiagen).
Serodiagnosis.
The recombinant E. canis P28
fusion protein was subjected to SDS-polyacrylamide gel electrophoresis
on 4 to 15% Tris-HCl gradient gels (Bio-Rad, Hercules, Calif.) and
transferred to pure nitrocellulose (Schleicher & Schuell, Keene, N.H.)
by using a semidry transfer cell (Bio-Rad). The membrane was incubated
with convalescent-phase antisera (1:50) from six E. canis-infected dogs for 1 h, washed, and then incubated with
an anti-canine immunoglobulin G (heavy plus light chains) alkaline
phosphatase-conjugated affinity-purified secondary antibody (Kirkegaard
& Perry Laboratories, Gaithersburg, Md.) at 1:1,000 for 1 h. Bound
antibody was visualized with 5-bromo-4-chloro-3-indolyl phosphate-nitroblue tetrazolium substrate (Kirkegaard & Perry Laboratories).
Southern blot analysis.
To determine if multiple genes
homologous to the p28 gene were present in the E. canis genome, a genomic Southern blot analysis was performed by a
standard procedure (25). E. canis genomic DNA was
digested completely with each of the restriction enzymes BanII, EcoRV, HaeII, KpnI,
and SpeI, which do not cut within the p28 gene,
and with AseI, which digests p28 at nucleotides
34, 43, and 656. The probe was produced by PCR amplification with primers EC28OM-F and EC28OM-R and digoxigenin (DIG)-labeled
deoxynucleotide triphosphates (Boehringer Mannheim) and digested
with AseI. The digested probe (566 bp) was separated by
agarose gel electrophoresis, gel purified, and then used for
hybridization. The completely digested genomic E. canis DNA
was electrophoresed, transferred to a nylon membrane (Boehringer
Mannheim), and hybridized at 40°C for 16 h with the
p28 gene DIG-labeled probe in DIG Easy Hyb buffer according
to the protocol of the manufacturer (Boehringer Mannheim). Bound probe
was detected with an anti-DIG alkaline phosphatase-conjugated antibody
and a luminescent substrate (Boehringer Mannheim) and exposed to BioMax
scientific imaging film (Eastman Kodak, Rochester, N.Y.).
Sequence analysis.
E. chaffeensis p28 and C. ruminantium map-1 DNA sequences were obtained from the National
Center for Biotechnology Information (16a). Nucleotide and
deduced amino acid sequence analyses and protein and phylogenetic
analyses were performed with LASERGENE software (DNASTAR, Inc.,
Madison, Wis.). Analysis of post-translational processing was performed
by the method of McGeoch (16) and von Heijne (28)
for signal sequence recognition with the PSORT program (20a).
Nucleotide sequence accession numbers.
The GenBank accession
numbers for the nucleic acid and amino acid sequences of the E. canis p28 genes described in this report are as follows: Jake,
AF082744; Louisiana, AF082745; Oklahoma, AF082746; Demon, AF082747; DJ,
AF082748; Fuzzy, AF082749; and Florida, AF082750.
 |
RESULTS |
PCR amplification, cloning, sequencing, and expression of the
E. canis p28 gene.
Alignment of nucleic acid sequences
from E. chaffeensis p28 and C. ruminantium map-1
by using the Jotun-Hein algorithm produced a consensus sequence with
regions of high homology (>90%). These homologous regions
(nucleotides 313 to 332 and 823 to 843 of C. ruminantium
map-1 and 307 to 326 and 814 to 834 of E. chaffeensis p28) were targeted as primer annealing sites for PCR
amplification. PCR amplification of the E. canis and
E. chaffeensis p28 genes was accomplished with primers 793 and 1330, resulting in a 518-bp PCR product. The nucleic acid sequence
of the E. canis PCR product was obtained by sequencing the
product directly with primers 793 and 1330. Analysis of the sequence
revealed an open reading frame encoding a protein of 170 amino acids,
and comparison of the 518-bp sequence obtained from PCR amplification
of E. canis with the DNA sequence of the E. chaffeensis p28 gene revealed homology greater than 70%. Adapter
PCR with primers 394 and 793C was performed to obtain the 5' and 3'
segments of the sequence of the entire gene. Primer 394 produced four
PCR products (3, 2, 1, and 0.8 kb), and the 0.8-bp product was
sequenced bidirectionally with primers 394 and AP1. The deduced
sequence overlapped with the 3' end of the 518-bp product, extending
the open reading frame 12 bp to a termination codon. An additional 625 bp of noncoding sequence at the 3' end of the p28 gene was
also sequenced. Primer 394C was used to amplify the 5' end of the
p28 gene with supplied primer AP1. Amplification with these
primers resulted in three PCR products (3.3, 3, and 2 kb). The 2-kb
fragment was sequenced unidirectionally with primer 793C. The sequence
provided the putative start codon of the p28 gene and
completed the 834-bp open reading frame encoding a protein of 278 amino
acids. An additional 144 bp of readable sequence in the 5' noncoding
region of the p28 gene was generated. Primers EC28OM-F and
EC28OM-R were designed from complementary noncoding regions adjacent to
the p28 gene. The PCR product amplified with these primers
was sequenced directly with the same primers. The complete DNA sequence
for the E. canis p28 gene is shown in Fig.
1. The p28 PCR fragment
amplified with these primers contained the entire open reading frame
and sequence encoding 17 additional amino acids from the 5' noncoding
primer region. The gene was directionally subcloned into the pThioHis expression vector, and E. coli (BL21) was transformed with
this construct. The expressed P28-thioredoxin fusion protein was
insoluble. The expressed protein had an additional 114 amino acids
associated with the thioredoxin, 5 amino acids for the enterokinase
recognition site, and 32 amino acids from the multiple cloning site and
5' noncoding primer region at the N terminus. Convalescent-phase antiserum from an E. canis-infected dog recognized the
expressed recombinant fusion protein but did not react with the
thioredoxin control (Fig. 2).

View larger version (53K):
[in this window]
[in a new window]
|
FIG. 1.
Nucleic acid sequence of the E. canis p28
gene, including adjacent 5' and 3' noncoding sequences. The ATG start
codon and TAA termination codon are shown in boldface, and the
23-amino-acid leader signal sequence is underlined.
|
|

View larger version (67K):
[in this window]
[in a new window]
|
FIG. 2.
SDS-polyacrylamide gel electrophoresis of expressed
50-kDa recombinant E. canis P28-thioredoxin fusion protein
(lane 1, arrow) and 16-kDa thioredoxin control (lane 2, arrow) and
corresponding immunoblot of recombinant E. canis
P28-thioredoxin fusion protein recognized by convalescent-phase
E. canis canine antiserum (lane 3). The thioredoxin control
antigen did not react with the E. canis antiserum (not
shown). Numbers on the left are molecular masses in kilodaltons.
|
|
Nucleic acid sequence homology.
The nucleic acid sequences of
E. canis p28 (834 bp) and the E. chaffeensis
omp-1 family of genes (p28 and omp-1A,
-1B, -1C, -1D, -1E, and
-1F), including signal sequences, were aligned by using the
Clustal method to examine homology between these genes (alignment not
shown). Nucleic acid homology was equally conserved (68.9%) between
E. canis p28 and E. chaffeensis p28 and
omp-1F. Other putative outer membrane protein genes in the
E. chaffeensis omp-1 family, i.e., omp-1D
(68.2%), omp-1E (66.7%), and omp-1C (64.1%),
C. ruminantium map-1 (61.8%), and the E. canis
28-kDa-protein 1 gene (60%) and 28-kDa-protein 2 gene (partial)
(59.5%), were also homologous to E. canis p28. E. chaffeensis
omp-1B had the least nucleic acid homology (45.1%) with E. canis p28.
Amino acid sequence homology.
Alignment of the predicted amino
acid sequences of E. canis P28 and E. chaffeensis
P28 revealed amino acid substitutions resulting in four variable
regions. Substitutions or deletions in the amino acid sequence and the
locations of variable regions of E. canis P28 and the
E. chaffeensis OMP-1 family were identified (Fig. 3). Amino acid comparison demonstrated
that the E. canis P28 protein had the most homology with
OMP-1F (68%) of the E. chaffeensis OMP-1 family, followed
by E. chaffeensis P28 (65.5%), OMP-1E (65.1%), OMP-1D
(62.9%), and OMP-1C (62.9%), C. ruminantium MAP-1
(59.4%), E. canis 28-kDa protein 1 (55.6%) and 28-kDa
protein 2 (partial) (53.6%), and E. chaffeensis OMP-1B
(43.2%). The phylogenetic relationships based on amino acid sequences
show that E. canis P28 and C. ruminantium MAP-1,
E. chaffeensis OMP-1 proteins, and E. canis
28-kDa proteins 1 and 2 (partial) are related (Fig.
4).

View larger version (34K):
[in this window]
[in a new window]
|
FIG. 3.
Alignment of E. canis P28 (ECaP28), E. canis 28-kDa protein 1 (ECa28-1) (complete) and 28-kDa protein 2 (ECa28-2) (partial), E. chaffeensis (ECh) OMP-1 family, and
C. ruminantium MAP-1 amino acid sequences. The E. canis P28 amino acid sequence is presented as the consensus
sequence. Amino acids not shown are identical to those of E. canis P28 and are represented by dots. Divergent amino acids are
shown with the corresponding one-letter abbreviations. Gaps introduced
for maximal alignment of the amino acid sequences are denoted with
dashes. Variable regions are underlined and denoted VR1, VR2, VR3, and
VR4. The arrow indicates the predicted signal peptidase cleavage site
for the signal peptide.
|
|

View larger version (7K):
[in this window]
[in a new window]
|
FIG. 4.
Phylogenetic relatedness of E. canis P28
(ECaP28) with the E. canis 28-kDa protein 1 (ECa28-1)
(complete) and 28-kDa protein 2 (ECa28-2) (partial), six members of the
E. chaffeensis (ECh) OMP-1 family, and C. rumanintium MAP-1 from deduced amino acid sequences by utilizing
unbalanced tree construction. The length of each pair of branches
represents the distance between the amino acid sequences of the pairs.
The scale measures the distance between sequences.
|
|
N-terminal signal sequence.
The amino acid sequence analysis
revealed that the entire E. canis P28 has a deduced
molecular mass of 30.5 kDa. The protein has a predicted N-terminal
signal peptide of 23 amino acids
(MNCKKILITTALISLMYSIPSIS) (Fig.
3), which is similar to that predicted for E. chaffeensis P28 (MNYKKILITSALISLISSLPGVSFS) and the OMP-1 protein family (19, 31). A preferred cleavage site for signal peptidases (SIS;
Ser-X-Ser) (20) is found at amino acids 21, 22, and 23. An
additional putative cleavage site at amino acid position 25 (MNCKKILITTALISLMYSIPSISSFS) identical to the predicted cleavage site
of E. chaffeensis P28 (SFS) was also present and would
result in a mature E. canis P28 with a predicted molecular
mass of 27.7 kDa. The signal cleavage site of the previously reported
E. canis 28-kDa protein 1 is predicted to be at amino acid
30. However, signal sequence analysis predicted that E. canis 28-kDa protein 2 had an uncleavable signal sequence.
Detection of homologous genomic copies of the E. canis
p28 gene.
Genomic Southern blot analysis of E. canis DNA was performed following complete independent digestions
with restriction enzymes BanII, EcoRV,
HaeII, KpnI, and SpeI, which do not
have restriction endonuclease sites in the p28 gene. In
addition, digestion with AseI, which has internal
restriction endonuclease sites at nucleotides 34, 43, and 656, revealed
the presence of at least three homologous p28 gene copies
(Fig. 5). Although E. canis
p28 has internal AseI restriction sites, the
DIG-labeled probe used in the hybridization experiment targeted a
region of the gene within a single DNA fragment generated by the
AseI digestion of the gene. Digestion of genomic DNA of
E. canis with AseI produced three bands
(approximately 566 bp, 850 bp, and 3 kb) that hybridized with the
p28 DNA probe, indicating the presence of multiple genes
homologous to p28 genes in the genome. Digestion with
EcoRV and SpeI produced two bands that hybridized
with the p28 gene probe.

View larger version (96K):
[in this window]
[in a new window]
|
FIG. 5.
Southern blot analysis of E. canis genomic
DNA completely digested with six individual restriction enzymes and
hybridized with a P28 DIG-labeled probe (lanes 2 to 7). Lanes 1 and 8, DIG-labeled molecular size markers (MWM).
|
|
Predicted surface probability and immunoreactivity.
Analysis
of E. canis P28 by hydropathy and hydrophilicity profiles
predicted surface-exposed regions on P28 (Fig.
6). Eight major surface-exposed regions
consisting of three to nine amino acids were identified on E. canis P28 and were similar to the profile of surface-exposed
regions on E. chaffeensis P28 (Fig. 6). Five of the larger
surface-exposed regions on E. canis P28 were located in the
N-terminal region of the protein. Surface-exposed hydrophilic regions
were found in all four of the variable regions of E. canis
P28. Ten T-cell motifs in E. canis P28 were predicted by
using the Rothbard-Taylor algorithm (24), and high
antigenicity of P28 was predicted by the Jameson-Wolf antigenicity
algorithm (Fig. 6) (13). Similarities in antigenicity and
T-cell motifs were observed between E. canis P28 and
E. chaffeensis P28.

View larger version (27K):
[in this window]
[in a new window]
|
FIG. 6.
Comparison of predicted protein characteristics of
E. canis P28 (Jake strain) and E. chaffeensis P28
(Arkansas strain). Surface probability predicts the surface residues by
using a window of hexapeptide. A surface residue is any residue with
>2.0 nm2 of water-accessible surface area. A hexapeptide
with a value higher than 1 was considered a surface region. The
antigenic index predicts potential antigenic determinants. The regions
with values above zero are potential antigenic determinants. T-cell
motif locates the potential T-cell antigenic determinants by using a
motif of five amino acids, with residue 1 glycine or polar, residue 2 hydrophobic, residue 3 hydrophobic, residue 4 hydrophobic or proline,
and residue 5 polar or glycine. The scale indicates amino acid
positions.
|
|
Homology of p28 gene sequences from different E. canis isolates.
The p28 genes from seven E. canis isolates, four from North Carolina and one each from
Florida, Oklahoma, and Louisiana, were amplified by PCR with primers
EC28OM-F and EC28OM-R and sequenced directly with the same primers.
Alignment of the p28 gene nucleic acid sequences revealed
that the p28 genes from these isolates were identical.
Serodiagnosis.
Sera from six clinical cases of canine
ehrlichiosis were incubated with the recombinant
protein in immunoblots at a 1:100 dilution. Antibodies in the sera of
five dogs (83%) reacted with the P28 recombinant protein (Fig.
7).

View larger version (93K):
[in this window]
[in a new window]
|
FIG. 7.
Immunoblot analysis of sera from six clinical cases of
canine ehrlichiosis (lanes 1 to 6) incubated with the 50-kDa
recombinant P28 fusion protein (arrow). Smaller reactive bands, which
may be degradative products of the P28 fusion protein, are also
visible.
|
|
 |
DISCUSSION |
Proteins with similar molecular masses have been identified and
cloned from multiple rickettsial agents, including E. canis, E. chaffeensis, and C. ruminantium (14, 19,
21). In this report, we demonstrated the cloning, expression, and
characterization of a gene encoding a mature 28-kDa protein of E. canis that is homologous to the omp-1 multiple-gene
family of E. chaffeensis and the C. ruminantium
map-1 gene. The E. canis p28 gene is also homologous,
but different from the previously reported E. canis 28-kDa-protein 1 gene (complete) and 28-kDa-protein 2 gene (partial) (21). Previous studies have identified a 30-kDa protein of
E. canis that reacts with convalescent-phase antisera
against E. chaffeensis, but this protein was believed to be
antigenically distinct (22). Our findings, based on
comparison of amino acid substitutions in four variable regions of
E. canis P28, support this possibility. Together these
findings also suggest that the amino acids responsible for the
antigenic differences between E. canis and E. chaffeensis P28 are located in these variable regions and are
readily accessible to the immune system. Reddy et al. (21)
reported that immunoreactive peptides were located in the variable
regions of the 28-kDa proteins of C. ruminantium, E. chaffeensis, and E. canis. Analysis of E. canis P28 and E. chaffeensis P28 revealed that all of
the variable regions have predicted surface-exposed amino acids. A
study with dogs demonstrated a lack of cross-protection between
E. canis and E. chaffeensis (7). This
observation may be related to antigenic differences in the variable
regions of P28 as well as in other immunologically important antigens
of these ehrlichial species. Another study found that
convalescent-phase human antisera from E. chaffeensis-infected patients recognized a 29- or 28-kDa
protein(s) of E. chaffeensis and also reacted with
homologous proteins of E. canis (5). Homologous
and cross-reactive epitopes on E. canis P28 and E. chaffeensis P28 appear to be recognized by the immune system.
Several reports have demonstrated that the 30-kDa antigen of E. canis exhibits strong immunoreactivity (22, 23).
Antibodies in convalescent-phase antisera from humans and dogs have
consistently reacted with proteins in this size range from E. chaffeensis and E. canis, suggesting that they may be
important serodiagnostic as well as immunoprotective antigens (5,
6, 22). In addition, antibodies to 30-, 24-, and 21-kDa proteins
develop early in the immune response to E. canis (22,
23), suggesting that these proteins may be especially important
in the immune response during the acute stage of disease and thus may
be particularly useful for serodiagnosis. In addition, a family of
homologous genes encoding outer membrane proteins with molecular masses
of 28 kDa have been identified in E. chaffeensis, and mice
immunized with recombinant E. chaffeensis P28 appeared to
have developed immunity against homologous challenge (19).
The P28 of E. chaffeensis has been demonstrated to be
present in the outer membrane, and immunoelectron microscopy has
localized the P28 on the surface of the organism, thus suggesting that
it may serve as an adhesin (19). It is likely that the P28
of E. canis identified in this study has a similar location
and function. The immunoprotective capacity of E. canis P28
is not known, but similar studies with E. chaffeensis P28
suggest that it may be a potential vaccine candidate.
There is evidence that the P28 from E. canis may be
posttranslationally processed from an immature 30-kDa protein to a
mature 28-kDa protein. Recently, a signal sequence was identified on E. chaffeensis P28 (31), and N-terminal amino
acid sequencing has verified that the protein is posttranslationally
processed, resulting in cleavage of the signal sequence to produce a
mature protein (19). Sequences of OMP-1F and OMP-1E have
also been proposed as leader signal peptides (19). Signal
sequences identified on E. chaffeensis OMP-1F, OMP-1E, and
P28 are homologous to the leader sequence of E. canis P28.
However, two N-terminal signal sequences were identified on E. canis P28 within a 5-amino-acid region (SISFS). The first signal
sequence produces a leader peptide two amino acids shorter than that
observed on the E. chaffeensis P28, due to a single amino
acid substitution (serine) at position 21. The second signal sequence
is identical to those on E. chaffeensis P28, OMP-1F, and
OMP-1E and produces a leader peptide consisting of 25 amino acids. The
homologies of the 25-amino-acid leader signal peptides of E. chaffeensis OMP-1F, OMP-1E, and P28 to E. canis P28 are
72, 68, and 64%, respectively. N-terminal amino acid sequencing could
verify the cleavage site of the signal sequence of E. canis
P28, but it is likely that the P28 E. canis protein that we
have cloned is subject to posttranslational modification similar to
that observed with E. chaffeensis P28.
Comparison of the p28 genes from different strains of
E. canis revealed that the gene is apparently completely
conserved. Studies involving E. chaffeensis have
demonstrated immunologic and molecular evidence of diversity in the
p28 gene. Patients infected with E. chaffeensis
have variable immunoreactivity to the 29- and 28-kDa proteins,
suggesting that there is antigenic diversity (5), and recent
molecular evidence has been generated to support antigenic diversity in
the p28 gene from E. chaffeensis (31).
However, differences in the host response to E. chaffeensis P28 may also explain some of the observed immunologic variability. A
comparison of the p28 genes of five E. chaffeensis isolates revealed that two isolates (Sapulpa and St.
Vincent) were 100% identical but that three others (Arkansas, Jax, and
91HE17) were divergent by as much as 13.4% at the amino acid level.
The conservation of E. canis p28 suggests that E. canis strains found in the United States may be genetically
identical, and thus E. canis p28 is an attractive vaccine
candidate for canine ehrlichiosis in the United States. Further
analysis of E. canis isolates outside the United States may
provide information regarding the origin and evolution of E. canis. The documented immunoreactivity and conservation of the P28
protein suggests that it may be a reliable serodiagnostic antigen, and
this proposal is further supported by the high rate of reactivity of
clinical canine ehrlichiosis specimens with P28 in our study.
The presence of multiple polymorphic genes homologous to E. canis P28 corresponds to the presence of similar multiple-gene families in E. chaffeensis and Anaplasma
marginale (1, 19). Six genes were found in the
omp-1 gene family of E. chaffeensis, and an
msp-3 multiple-gene family has been described for A. marginale. In our study, Southern blot hybridization of E. canis genomic DNA (Jake strain) digested with AseI and
hybridized with a DIG-labeled p28 probe revealed the
presence of at least three gene copies that were homologous to the
p28 gene. The restriction enzyme AseI cuts within
the p28 gene; however, the p28 probe was designed to be complementary with sequences internal to the AseI
restriction sites. In addition, AseI cuts within the
noncoding region found between the tandemly arranged E. canis 28-kDa-protein genes described previously (21).
Thus, the three p28 genes would be found on separate DNA
fragments. The largest fragment from the AseI digest (3 kb)
that hybridized with the p28 probe is at least three times larger than the p28 gene. Therefore, the possibility of
additional genes within this 3-kb fragment that are homologous to
p28, and different from those already reported, cannot be
eliminated. The hybridization pattern does suggest that all
p28 gene copies may be tandemly arranged along a single
stretch of DNA. The role of multiple homologous genes is not known at
this point; however, persistence of E. canis infections in
dogs could conceivably be related to antigenic variation due to
variable expression of homologous p28 genes, thus enabling
E. canis to evade immune surveillance. Variation of
msp-3 genes in A. marginale is partially
responsible for variation in the MSP-3 protein, resulting in persistent
infections (1). In addition, temperature-related gene
expression resulting in phenotypic changes in Borrelia
hermsii has also been reported (26). Studies to examine
p28 gene expression by E. canis in acutely and
chronically infected dogs would provide insight into the role of the
p28 gene family in persistent E. canis infections.
 |
ACKNOWLEDGMENTS |
This study was supported by funding from the Clayton Foundation
for Research.
We thank Patricia Crocquet-Valdes and John Stenos for helpful technical
assistance and Josie Ramirez-Kim for expert secretarial assistance with
the preparation of the manuscript.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Department of
Pathology, University of Texas Medical Branch, 301 University Blvd., Galveston, TX 77555-0609. Phone: (409) 772-2856. Fax: (409) 772-2500. E-mail: dwalker{at}utmb.edu.
 |
REFERENCES |
| 1.
|
Alleman, A. R.,
G. H. Palmer,
T. C. McGuire,
T. F. McElwain,
L. E. Perryman, and A. F. Barbet.
1997.
Anaplasma marginale major surface protein 3 is encoded by a polymorphic, multigene family.
Infect. Immun.
65:156-163[Abstract].
|
| 2.
|
Anderson, B. E.,
J. E. Dawson,
D. C. Jones, and K. H. Wilson.
1991.
Ehrlichia chaffeensis, a new species associated with human ehrlichiosis.
J. Clin. Microbiol.
29:2838-2842[Abstract/Free Full Text].
|
| 3.
|
Anderson, B. E.,
C. E. Greene,
D. C. Jones, and J. E. Dawson.
1992.
Ehrlichia ewingii sp. nov., the etiologic agent of canine granulocytic ehrlichiosis.
Int. J. Syst. Bacteriol.
42:299-302[Abstract/Free Full Text].
|
| 4.
|
Brouqui, P.,
J. S. Dumler,
D. Raoult, and D. H. Walker.
1992.
Antigenic characterization of ehrlichiae: protein immunoblotting of Ehrlichia canis, Ehrlichia sennetsu, and Ehrlichia risticii.
J. Clin. Microbiol.
30:1062-1066[Abstract/Free Full Text].
|
| 5.
|
Chen, S. M.,
L. C. Cullman, and D. H. Walker.
1997.
Western immunoblotting analysis of the antibody responses of patients with human monocytotropic ehrlichiosis to different strains of Ehrlichia chaffeensis and Ehrlichia canis.
Clin. Diagn. Lab. Immunol.
4:731-735[Abstract].
|
| 6.
|
Chen, S. M.,
J. S. Dumler,
H.-M. Feng, and D. H. Walker.
1994.
Identification of the antigenic constituents of Ehrlichia chaffeensis.
Am. J. Trop. Med. Hyg.
50:52-58.
|
| 7.
|
Dawson, J. E., and S. A. Ewing.
1992.
Susceptibility of dogs to infection with Ehrlichia chaffeensis, causative agent of human ehrlichiosis.
Am. J. Vet. Res.
53:1322-1327[Medline].
|
| 8.
|
Dawson, J. E.,
Y. Rikihisa,
S. A. Ewing, and D. B. Fishbein.
1991.
Serologic diagnosis of human ehrlichiosis using two Ehrlichia canis isolates.
J. Infect. Dis.
163:564-567[Medline].
|
| 9.
|
Donatien, A., and F. Lestoquard.
1935.
Existance in Algerie d'une Rickettsia du chein.
Bull. Soc. Pathol. Exot.
28:418-419.
|
| 10.
|
Ewing, S. A.
1963.
Observations of leukocytic inclusion bodies from dogs infected with Babesia canis.
J. Am. Vet. Med. Assoc.
143:503-506[Medline].
|
| 11.
|
Groves, M. G.,
G. L. Dennis,
H. L. Amyx, and D. L. Huxsoll.
1975.
Transmission of Ehrlichia canis to dogs by ticks (Rhipicephalus sanguineus).
Am. J. Vet. Res.
36:937-940[Medline].
|
| 12.
|
Harrus, S.,
T. Waner,
I. Aizenberg,
J. E. Foley,
A. M. Poland, and H. Bark.
1998.
Amplification of ehrlichial DNA from dogs 34 months after infection with Ehrlichia canis.
J. Clin. Microbiol.
36:73-76[Abstract/Free Full Text].
|
| 13.
|
Jameson, B. A., and H. Wolf.
1988.
The antigenic index: a novel algorithm for predicting antigenic determinants.
CABIOS
4:181-186[Abstract/Free Full Text].
|
| 14.
|
Jongejan, F.,
N. de Vries,
J. Nieuwenhuijs,
A. H. Van Vliet, and L. A. Wassink.
1993.
The immunodominant 32-kilodalton protein of Cowdria ruminantium is conserved within the genus Ehrlichia.
Rev. Elev. Med. Vet. Pays. Trop.
46:145-152[Medline].
|
| 15.
|
McBride, J. W.,
R. E. Corstvet,
S. D. Gaunt,
J. Chinsangaram,
G. Y. Akita, and B. I. Osburn.
1996.
PCR detection of acute Ehrlichia canis infection in dogs.
J. Vet. Diagn. Invest.
8:441-447[Abstract/Free Full Text].
|
| 16.
|
McGeoch, D. J.
1985.
On the predictive recognition of signal peptide sequences.
Virus Res.
3:271-286[Medline].
|
| 16a.
| National Center for Biotechnology Information. 6 March 1998, posting date. Sequences. [Online.]
http://www.ncbi.nlm.nih.gov/Entrez. [10 August 1998, last date
accessed.]
|
| 17.
|
Nyindo, M.,
I. Kakoma, and R. Hansen.
1991.
Antigenic analysis of four species of the genus Ehrlichia by use of protein immunoblot.
Am. J. Vet. Res.
52:1225-1230[Medline].
|
| 18.
|
Nyindo, M. B.,
M. Ristic,
D. L. Huxsoll, and A. R. Smith.
1971.
Tropical canine pancytopenia: in vitro cultivation of the causative agent Ehrlichia canis.
Am. J. Vet. Res.
32:1651-1658[Medline].
|
| 19.
|
Ohashi, N.,
N. Zhi,
Y. Zhang, and Y. Rikihisa.
1998.
Immunodominant major outer membrane proteins of Ehrlichia chaffeensis are encoded by a polymorphic multigene family.
Infect. Immun.
66:132-139[Abstract/Free Full Text].
|
| 20.
|
Oliver, D.
1985.
Protein secretion in Escherichia coli.
Annu. Rev. Microbiol.
39:648.
|
| 20a.
| PSORT. 5 June 1998, posting date. [Online.] PSORT
program. http://www.imcb.osaka-u.ac.jp/nakai/form.htm. [16 July
1998, last date accessed.]
|
| 21.
|
Reddy, G. R.,
C. R. Sulsona,
A. F. Barbet,
S. M. Mahan,
M. J. Burridge, and A. R. Alleman.
1998.
Molecular characterization of a 28 kDa surface antigen gene family of the tribe Ehrlichiae.
Biochem. Biophys. Res. Commun.
247:636-643[Medline].
|
| 22.
|
Rikihisa, Y.,
S. A. Ewing, and J. C. Fox.
1994.
Western immunoblot analysis of Ehrlichia chaffeensis, E. canis, or E. ewingii infections in dogs and humans.
J. Clin. Microbiol.
32:2107-2112[Abstract/Free Full Text].
|
| 23.
|
Rikihisa, Y.,
S. A. Ewing,
J. C. Fox,
A. G. Siregar,
F. H. Pasaribu, and M. B. Malole.
1992.
Analysis of Ehrlichia canis and a canine granulocytic Ehrlichia infection.
J. Clin. Microbiol.
30:143-148[Abstract/Free Full Text].
|
| 24.
|
Rothbard, J. B., and W. R. Taylor.
1988.
A sequence pattern common to T cell epitopes.
EMBO J.
7:93-100[Medline].
|
| 25.
|
Sambrook, J.,
E. F. Fritsch, and T. Maniatis.
1989.
Molecular cloning: a laboratory manual, 2nd ed., p. 9.34-9.58.
Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.
|
| 26.
|
Schwan, T. G., and J. Hinnebusch.
1998.
Bloodstream-versus tick-associated variants of a relapsing fever bacterium.
Science
280:1938-1940[Abstract/Free Full Text].
|
| 27.
|
Troy, G. C., and S. D. Forrester.
1990.
Canine ehrlichiosis, p. 404-414.
In
C. E. Green (ed.), Infectious diseases of the dog and cat. W. B. Saunders Co., Philadelphia, Pa.
|
| 28.
|
von Heijne, G.
1986.
A new method for predicting signal sequence cleavage sites.
Nucleic Acids. Res.
14:4683-4690[Abstract/Free Full Text].
|
| 29.
|
Walker, J. S.,
J. D. Rundquist,
R. Taylor,
B. L. Wilson,
M. R. Andrews,
J. Barck,
A. L. J. Hogge,
D. L. Huxsoll,
P. K. Hildebrandt, and R. M. Nims.
1970.
Clinical and clinicopathologic findings in tropical canine pancytopenia.
J. Am. Vet. Med. Assoc.
157:43-55[Medline].
|
| 30.
|
Weiss, E.,
J. C. Coolbaugh, and J. C. Williams.
1975.
Separation of viable Rickettsia typhi from yolk sac and L cell host components by renograffin density gradient centrifugation.
Appl. Microbiol.
30:456-463[Medline].
|
| 31.
|
Yu, X. J.,
J. W. McBride, and D. H. Walker.
1999.
Genetic diversity of the 28-kilodalton outer membrane protein gene in human isolates of Ehrlichia chaffeensis.
J. Clin. Microbiol.
37:1137-1143[Abstract/Free Full Text].
|
Clinical and Diagnostic Laboratory Immunology, May 1999, p. 392-399, Vol. 6, No. 3
1071-412X/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Cardenas, A. M., Doyle, C. K., Zhang, X., Nethery, K., Corstvet, R. E., Walker, D. H., McBride, J. W.
(2007). Enzyme-Linked Immunosorbent Assay with Conserved Immunoreactive Glycoproteins gp36 and gp19 Has Enhanced Sensitivity and Provides Species-Specific Immunodiagnosis of Ehrlichia canis Infection. CVI
14: 123-128
[Abstract]
[Full Text]
-
Yager, E., Bitsaktsis, C., Nandi, B., McBride, J. W., Winslow, G.
(2005). Essential Role for Humoral Immunity during Ehrlichia Infection in Immunocompetent Mice. Infect. Immun.
73: 8009-8016
[Abstract]
[Full Text]
-
McBride, J. W., Corstvet, R. E., Gaunt, S. D., Boudreaux, C., Guedry, T., Walker, D. H.
(2003). Kinetics of Antibody Response to Ehrlichia canis Immunoreactive Proteins. Infect. Immun.
71: 2516-2524
[Abstract]
[Full Text]
-
Cheng, C., Paddock, C. D., Reddy Ganta, R.
(2003). Molecular Heterogeneity of Ehrlichia chaffeensis Isolates Determined by Sequence Analysis of the 28-Kilodalton Outer Membrane Protein Genes and Other Regions of the Genome. Infect. Immun.
71: 187-195
[Abstract]
[Full Text]
-
Stich, R. W., Rikihisa, Y., Ewing, S. A., Needham, G. R., Grover, D. L., Jittapalapong, S.
(2002). Detection of Ehrlichia canis in Canine Carrier Blood and in Individual Experimentally Infected Ticks with a p30-Based PCR Assay. J. Clin. Microbiol.
40: 540-546
[Abstract]
[Full Text]
-
Gusa, A. A., Buller, R. S., Storch, G. A., Huycke, M. M., Machado, L. J., Slater, L. N., Stockham, S. L., Massung, R. F.
(2001). Identification of a p28 Gene in Ehrlichia ewingii: Evaluation of Gene for Use as a Target for a Species-Specific PCR Diagnostic Assay. J. Clin. Microbiol.
39: 3871-3876
[Abstract]
[Full Text]
-
McBride, J. W., Corstvet, R. E., Breitschwerdt, E. B., Walker, D. H.
(2001). Immunodiagnosis of Ehrlichia canis Infection with Recombinant Proteins. J. Clin. Microbiol.
39: 315-322
[Abstract]
[Full Text]